Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

The inhibitory receptor CTLA4 has a key role in peripheral tolerance of T cells for both normal and tumor-associated antigens. Murine experiments suggested that blockade of CTLA4 might have antitumor activity and a clinical experience with the blocking antibody ipilimumab in patients with metastatic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yang, James C., Hughes, Marybeth, Kammula, Udai, Royal, Richard, Sherry, Richard M., Topalian, Suzanne L., Suri, Kimberly B., Levy, Catherine, Allen, Tamika, Mavroukakis, Sharon, Lowy, Israel, White, Donald E., Rosenberg, Steven A.
Format: Artigo
Langue:Inglês
Publié: 2007
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2134980/
https://ncbi.nlm.nih.gov/pubmed/18049334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e318156e47e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires